×
About 8,810 results

ALLMedicine™ Anaphylaxis Center

Research & Reviews  2,620 results

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
https://europepmc.org/article/pmc/pmc8441702
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Allergenic characterization of Bomb m 4, a 30 kDa lipoprotein Bombyx mori lipoprotein 6...
https://doi.org/10.1111/cea.14095
Clinical and Experimental Allergy : Journal of the Britis... Jeong KY, Lee J et. al.

Jan 15th, 2022 - Silkworm pupa (SWP) food anaphylaxis has been described frequently in Asian countries. However, false-positive reactions by skin pricks and serum IgE (sIgE) tests to the extract complicate diagnosis, requiring identification of clinically relevant...

Sugammadex and Decreased Time to Extubation
https://clinicaltrials.gov/ct2/show/NCT03196167

Jan 14th, 2022 - Primary Efficacy Objective: To demonstrate faster time to extubation after arrival in the cardiothoracic ICU in patients having a CABG who receive Sugammadex 2mg/kg as compared to placebo. Hypotheses: We hypothesize that the use of Sugammadex for ...

Combining Failure Modes and Effects Analysis and Cause-Effect Analysis: A Novel Method ...
https://doi.org/10.1093/intqhc/mzac002
International Journal for Quality in Health Care : Journa... Koike D, Yamakami J et. al.

Jan 14th, 2022 - Contrast media agents are essential for computed tomography-based diagnoses. However, they can cause fatal adverse effects such as anaphylaxis in patients. Although it is rare, the chances of anaphylaxis increase with the number of examinations. T...

Sugammadex Versus Neostigmine for Reversal of Residual Neuromuscular Blocks After Surge...
https://doi.org/10.1213/ANE.0000000000005842
Anesthesia and Analgesia; Ruetzler K, Li K et. al.

Jan 13th, 2022 - Sugammadex and neostigmine given to reverse residual neuromuscular blockade can cause side effects including bradycardia, anaphylaxis, bronchospasm, and even cardiac arrest. We tested the hypothesis that sugammadex is noninferior to neostigmine on...

see more →

Guidelines  14 results

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
https://europepmc.org/article/pmc/pmc8441702
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802368
MMWR. Recommendations and Reports : Morbidity and Mortali... Choi MJ, Cossaboom CM et. al.

Jan 9th, 2021 - This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant human serum albumin and...

STAT: Anaphylaxis.
https://doi.org/10.1188/20.CJON.336
Clinical Journal of Oncology Nursing;

May 23rd, 2020 - Anaphylaxis is a severe, potentially life-threatening acute allergic reaction that involves more than one system of the body.

AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (M...
https://doi.org/10.1016/j.jaci.2019.08.023
The Journal of Allergy and Clinical Immunology; Weiler CR, Austen KF et. al.

Sep 3rd, 2019 - Our current recommendations for diagnosing and treating primary mast cell (MC) activation syndrome make use of the latest studies and consensus guidelines for clinically recognizing systemic anaphylaxis in real time, regardless of whether allergen...

Guideline review: Epinephrine use in anaphylaxis (AAP guideline 2017).
https://doi.org/10.1136/archdischild-2017-314592
Archives of Disease in Childhood. Education and Practice ... Goodall N

Nov 18th, 2018 - Guideline review: Epinephrine use in anaphylaxis (AAP guideline 2017).|2018|Goodall N,|drug therapy,therapeutic use,therapeutic use,

see more →

Drugs  304 results see all →

Clinicaltrials.gov  65 results

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
https://europepmc.org/article/pmc/pmc8441702
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Sugammadex and Decreased Time to Extubation
https://clinicaltrials.gov/ct2/show/NCT03196167

Jan 14th, 2022 - Primary Efficacy Objective: To demonstrate faster time to extubation after arrival in the cardiothoracic ICU in patients having a CABG who receive Sugammadex 2mg/kg as compared to placebo. Hypotheses: We hypothesize that the use of Sugammadex for ...

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
https://clinicaltrials.gov/ct2/show/NCT04950504

Dec 17th, 2021 - Subjects who meet all inclusion and no exclusion criteria after initial screening assessments will undergo a Skin Prick Test (SPT) followed by a baseline Double-Blind, Placebo-Controlled Food Challenge (DBPCFC) consisting of peanut and placebo (oa...

Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia
https://clinicaltrials.gov/ct2/show/NCT05110469

Nov 8th, 2021 - Study Design This was double-blinded randomized clinical trial that was conducted in Dr. Cipto Mangunkusumo National General Hospital in February - June 2021 after due permission from Ethics Committee of the Faculty of Medicine University of Indon...

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
https://clinicaltrials.gov/ct2/show/NCT01675882

Oct 27th, 2021 - Peanut allergy is a common allergy in the United States, with a prevalence in the general population as high as 1%. Peanut allergy management is based on strict peanut avoidance and injectable epinephrine after the allergic systemic reactions have...

see more →

News  478 results

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
https://europepmc.org/article/pmc/pmc8441702
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

Clear Food Labels Needed for People Allergic to Sesame
https://www.medscape.com/viewarticle/965855

Jan 3rd, 2022 - Among people who reported an allergic reaction to sesame in a survey, more than half (56%) of the triggering foods did not declare sesame on the label. The findings were published online last month in Annals of Allergy, Asthma and Immunology. Some...

Antibody Combo Gets EUA to Prevent COVID in Vulnerable Groups
https://www.medpagetoday.com/infectiousdisease/covid19/96088

Dec 8th, 2021 - The FDA authorized a long-acting monoclonal antibody combination, tixagevimab-cilgavimab (Evusheld), to prevent COVID-19 in immunocompromised individuals and those with a history of a severe vaccine reaction, the agency said on Wednesday. In its e...

New Type of Hepatitis B Vaccine OK'd
https://www.medpagetoday.com/gastroenterology/hepatitis/95983

Dec 2nd, 2021 - The FDA approved the first three-antigen hepatitis B vaccine (PreHevbrio) to prevent infection from all known subtypes in adults, VBI Vaccines announced on Wednesday. Approval for the recombinant vaccine -- which contains the S, pre-S1, and pre-S2...

New COVID-19 Vaccine Shows Good Efficacy and Toxicity Profile
https://www.medscape.com/viewarticle/963231

Nov 18th, 2021 - A randomised, double-blind, placebo-controlled, multicentre, phase 3 clinical trial has found that a new SARS-CoV-2 vaccine is “highly efficacious against laboratory-confirmed symptomatic COVID-19 disease”. Covaxin (code-named BBV152) is a whole v...

see more →

Patient Education  43 results see all →